Is there addiction to levodopa in patients with Parkinson's disease?
Merims
D
D
Department of Neurology, Rabin Medical Center-Belinson Campus, and the Sackler School of Medicine, Tel Aviv University, Petach Tiqva, Israel.
Galili-Mosberg
R
R
Melamed
E
E
D000368:Aged; D000978:Antiparkinson Agents / Q000008:administration & dosage / Q000009:adverse effects*; D016739:Behavior, Addictive; D004305:Dose-Response Relationship, Drug; D006801:Humans; D007980:Levodopa / Q000008:administration & dosage / Q000009:adverse effects*; D008297:Male; D010300:Parkinson Disease / Q000150:complications / Q000188:drug therapy* / Q000503:physiopathology / Q000523:psychology*; D011782:Quadriplegia / Q000150:complications; D013375:Substance Withdrawal Syndrome
D000978:Antiparkinson Agents; D007980:Levodopa